FBPase inhibitors (Chinese Academy of Medical Sciences)

N/A

Report date: 2025/01/26 18:11:00
NME

Base Information

Drug NameFBPase inhibitors (Chinese Academy of Medical Sciences)
Drug Alias NameBJB-2936
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFructose-1,6-bisphosphatase inhibitors
TargetsFructose-1,6-bisphosphatase
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A